Thu Dec 18 01:37:13 UTC 2025: ## U.S. House Passes Bill Banning Gender-Affirming Care for Minors
Washington, D.C. – December 18, 2025 – The U.S. House of Representatives passed a controversial bill on Wednesday that would outlaw gender-affirming treatments for transgender children, effectively banning procedures considered crucial for their well-being. The bill, championed by Representative Marjorie Taylor Greene (R-GA), passed with a 216-211 vote and now moves to the Senate, where its future remains uncertain.
The bill, presented as a measure to prevent “genital or bodily mutilation of a minor,” would criminalize various gender-affirming procedures currently available to transgender youth in some states. While explicitly targeting female genital mutilation, it also aims to restrict surgeries and pharmacological interventions, like puberty blockers, intended to align a minor’s body with their gender identity. Violators could face up to 10 years in prison and significant fines.
Greene framed the bill as a fulfillment of President Trump’s executive order and Republican campaign promises from 2024, referencing the administration’s efforts to restrict transgender rights in areas like military service and athletics.
The bill has drawn sharp criticism from Democratic lawmakers and transgender rights advocates. Representative Sarah McBride (D-DE), the first openly transgender person elected to Congress, accused Republicans of prioritizing wealth accumulation and attacking transgender people.
The Advocates for Trans Equality (A4TE) condemned the bill as an attempt to strip transgender and intersex individuals of their bodily autonomy. The organization also criticized the bill’s allowance of surgeries on intersex children, arguing they constitute non-consensual mutilation. “The bill is not about protecting children — it is about enforcing outdated ideas of sex and gender through coercion and violence,” stated A4TE health policy analyst Sinead Murano-Kinney.
The outcome of the bill in the Senate remains to be seen, setting the stage for a potentially heated debate over transgender rights and the role of government in healthcare decisions.
First Piper 